This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Pancreatic cancer patients responded to every-2- weeks treatment with gemcitabine plus cisplatin (GemCis).
We care about your feedback. Let us know how we can improve your CancerCompass experience.